{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:00:43Z","timestamp":1780657243874,"version":"3.54.1"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL151738"],"award-info":[{"award-number":["R01HL151738"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["23CDA1044815"],"award-info":[{"award-number":["23CDA1044815"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.semcancer.2025.12.008","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:55:05Z","timestamp":1766508905000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Heartbreakers and healers: RNA rebels in cardio-oncology"],"prefix":"10.1016","volume":"119","author":[{"given":"Celestina","family":"Agyemang-Dua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5868-3807","authenticated-orcid":false,"given":"Cristina","family":"Espinosa-Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2025.12.008_bib1","unstructured":"Cancer, \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer\u3009."},{"key":"10.1016\/j.semcancer.2025.12.008_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/bph.16416","article-title":"Non-coding RNAs and their potential exploitation in cancer therapy-related cardiotoxicity","volume":"182","author":"Bernasconi","year":"2025","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.semcancer.2025.12.008_bib3","doi-asserted-by":"crossref","first-page":"H160","DOI":"10.1152\/ajpheart.00418.2018","article-title":"Noncoding RNAs: potential regulators in cardioncology","volume":"316","author":"Chatterjee","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib4","first-page":"309","article-title":"Cardiotoxicity of anticancer treatments: epidemiology, detection, and management","volume":"66","author":"Curigliano","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2025.12.008_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8416763","article-title":"Oxidative stress: harms and benefits for human health","volume":"2017","author":"Pizzino","year":"2017","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.semcancer.2025.12.008_bib6","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/j.jacc.2013.01.090","article-title":"Cardiac complications of thoracic irradiation","volume":"61","author":"Jaworski","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0925-4439(02)00144-8","article-title":"Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis","volume":"1588","author":"Green","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcancer.2025.12.008_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tips.2022.10.003","article-title":"Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity","volume":"44","author":"Wu","year":"2023","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.semcancer.2025.12.008_bib9","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1200\/JCO.2017.76.3920","article-title":"Cardiovascular disease in survivors of childhood cancer: insights into epidemiology, pathophysiology, and prevention","volume":"36","author":"Armenian","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16081450","article-title":"Cancer and cardiovascular disease: the conjoined twins","volume":"16","author":"Zmaili","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2025.12.008_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.037965","article-title":"Specific cardiovascular mortality in cancer survivors: a nationwide population-based cohort study in Japan","volume":"14","author":"Gon","year":"2025","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.semcancer.2025.12.008_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaccao.2022.01.100","article-title":"Incident cardiovascular disease among adults with cancer: a population-based cohort study","volume":"4","author":"Paterson","year":"2022","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.semcancer.2025.12.008_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.hlc.2024.11.010","article-title":"Cardiotoxicity beyond cardiomyocytes-focus on the role of cardiac fibroblasts and endothelial cells","volume":"34","author":"Appels","year":"2025","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.semcancer.2025.12.008_bib16","unstructured":"Cancer Treatment-Related Cardiotoxicity, <\u3008https:\/\/epi.grants.cancer.gov\/cardiotoxicity\/\u3009> (."},{"key":"10.1016\/j.semcancer.2025.12.008_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340311799960645","article-title":"3rd. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment","volume":"7","author":"Volkova","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.semcancer.2025.12.008_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.semcancer.2025.12.008_bib19","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41569-020-0348-1","article-title":"Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia","volume":"17","author":"Herrmann","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","article-title":"Fulminant myocarditis with combination immune checkpoint blockade","volume":"375","author":"Johnson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2025.12.008_bib21","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.biocel.2005.04.011","article-title":"Cardiomyocytes structure, function and associated pathologies","volume":"37","author":"Woodcock","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fcell.2020.00434","article-title":"Molecular mechanisms of cardiomyocyte death in drug-induced cardiotoxicity","volume":"8","author":"Ma","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108116","article-title":"Endothelial dysfunction as a complication of anti-cancer therapy","volume":"237","author":"Terwoord","year":"2022","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.semcancer.2025.12.008_bib24","doi-asserted-by":"crossref","first-page":"H705","DOI":"10.1152\/ajpheart.00370.2019","article-title":"Detrimental effects of chemotherapy on human coronary microvascular function","volume":"317","author":"Hader","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/jrr\/rrab032","article-title":"DNA damage response in vascular endothelial senescence: Implication for radiation-induced cardiovascular diseases","volume":"62","author":"Nagane","year":"2021","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115361","article-title":"Navigating cancer therapy induced cardiotoxicity: from pathophysiology to treatment innovations","volume":"211","author":"Tetterton-Kellner","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.semcancer.2025.12.008_bib27","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.semcancer.2025.12.008_bib28","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.semcancer.2025.12.008_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1040-8428(97)10007-5","article-title":"Anthracycline-induced cardiotoxicity in children and young adults","volume":"27","author":"Giantris","year":"1998","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib30","unstructured":"Santos, D.S. d. & Goldenberg, R.C. d S. in Cardiotoxicity Ch. Chapter 1, (2018)."},{"key":"10.1016\/j.semcancer.2025.12.008_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158376","article-title":"Deficiency in cardiolipin reduces doxorubicin-induced oxidative stress and mitochondrial damage in human B-lymphocytes","volume":"11","author":"Aryal","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2025.12.008_bib32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/srep25333","article-title":"Modeling doxorubicin-induced cardiotoxicity in human pluripotent stem cell derived-cardiomyocytes","volume":"6","author":"Maillet","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2025.12.008_bib34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jacbts.2018.06.005","article-title":"Role of endothelium in doxorubicin-induced cardiomyopathy","volume":"3","author":"Luu","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.semcancer.2025.12.008_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.194316","article-title":"Characterization of anti-cancer therapy-induced microvascular dysfunction in breast cancer patients with proof-of-concept of targeted intervention","author":"Terwoord","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.semcancer.2025.12.008_bib36","first-page":"33585","article-title":"Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen","volume":"275","author":"Kotamraju","year":"2000","journal-title":"Role React. Oxyg. Nitrogen Species J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2025.12.008_bib37","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1161\/CIRCRESAHA.122.321587","article-title":"Critical role of the cGAS-STING pathway in doxorubicin-induced cardiotoxicity","volume":"132","author":"Luo","year":"2023","journal-title":"Circ. Res"},{"key":"10.1016\/j.semcancer.2025.12.008_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clon.2004.09.016","article-title":"Cardiac complications of radiation therapy","volume":"17","author":"Gaya","year":"2005","journal-title":"Clin. Oncol. (R. Coll. Radio.)"},{"key":"10.1016\/j.semcancer.2025.12.008_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00412-017-0658-1","article-title":"Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes","volume":"127","author":"Ranjha","year":"2018","journal-title":"Chromosoma"},{"key":"10.1016\/j.semcancer.2025.12.008_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1667\/RR14891.1","article-title":"Radiation-induced long noncoding RNAs in a mouse model after whole-body irradiation","volume":"189","author":"Aryankalayil","year":"2018","journal-title":"Radiat. Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib41","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12967-021-02998-w","article-title":"Analysis of lncRNA-miRNA-mRNA expression pattern in heart tissue after total body radiation in a mouse model","volume":"19","author":"Aryankalayil","year":"2021","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2025.12.008_bib42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrc2393","article-title":"Telomere dysfunction and tumour suppression: the senescence connection","volume":"8","author":"Deng","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2025.12.008_bib43","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.freeradbiomed.2017.04.019","article-title":"Ionizing radiation induces long-term senescence in endothelial cells through mitochondrial respiratory complex II dysfunction and superoxide generation","volume":"108","author":"Lafargue","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.semcancer.2025.12.008_bib44","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/ATVBAHA.124.319866","article-title":"Radiation-induced macrovessel\/microvessel disease","volume":"44","author":"Abe","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib45","doi-asserted-by":"crossref","first-page":"82049","DOI":"10.18632\/oncotarget.18282","article-title":"Ionising radiation increases permeability of endothelium through ADAM10-mediated cleavage of VE-cadherin","volume":"8","author":"Kabacik","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2025.12.008_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1252014","article-title":"Radiation induces acute and subacute vascular regression in a three-dimensional microvasculature model","volume":"13","author":"Choi","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib47","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10557-021-07181-3","article-title":"The molecular mechanisms of cardiotoxicity induced by HER2, VEGF, and tyrosine kinase inhibitors: an updated review","volume":"36","author":"Wu","year":"2022","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.semcancer.2025.12.008_bib48","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/ATVBAHA.124.319864","article-title":"Endothelium as a source of cardiovascular toxicity from antitumor kinase inhibitors","volume":"44","author":"Travers","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib49","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.2174\/13816128113199990590","article-title":"VEGF signaling in cancer treatment","volume":"20","author":"Sia","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.semcancer.2025.12.008_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaccao.2019.08.012","article-title":"Increase in blood pressure associated with tyrosine kinase inhibitors targeting vascular endothelial growth factor","volume":"1","author":"Waliany","year":"2019","journal-title":"JACC CardioOncol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib51","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1042\/CS20240537","article-title":"Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors","volume":"138","author":"Camarda","year":"2024","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.semcancer.2025.12.008_bib52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11912-022-01224-0","article-title":"VEGF receptor inhibitor-induced hypertension: emerging mechanisms and clinical implications","volume":"24","author":"Camarda","year":"2022","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.semcancer.2025.12.008_bib53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ctrv.2016.12.002","article-title":"Cardiovascular toxicity of angiogenesis inhibitors in treatment of malignancy: a systematic review and meta-analysis","volume":"53","author":"Abdel-Qadir","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.semcancer.2025.12.008_bib54","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1161\/HYPERTENSIONAHA.122.19427","article-title":"VEGF (Vascular Endothelial Growth Factor) inhibition and hypertension: does microvascular rarefaction play a role?","volume":"80","author":"le Noble","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.semcancer.2025.12.008_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ajh\/hpt201","article-title":"Vascular endothelial growth factor inhibitor-induced hypertension: from pathophysiology to prevention and treatment based on long-acting nitric oxide donors","volume":"27","author":"Kruzliak","year":"2014","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.semcancer.2025.12.008_bib56","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.2459\/JCM.0000000000000377","article-title":"Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors","volume":"17","author":"Maurea","year":"2016","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.semcancer.2025.12.008_bib57","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.semcancer.2025.12.008_bib58","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","article-title":"Integrated lncRNA function upon genomic and epigenomic regulation","volume":"82","author":"Herman","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcancer.2025.12.008_bib59","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2025.12.008_bib60","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12885-024-13305-3","article-title":"A meta-analysis of risk factors for cardiovascular adverse events with anthracycline based chemotherapy in lymphoma patients","volume":"25","author":"Dai","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2025.12.008_bib61","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1002\/ejhf.1920","volume":"22","author":"Lyon","year":"2020","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.semcancer.2025.12.008_bib62","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yjmcc.2015.01.011","article-title":"Noncoding RNA in age-related cardiovascular diseases","volume":"83","author":"Greco","year":"2015","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.959208","article-title":"Long non-coding RNA PVT1: a promising chemotherapy and radiotherapy sensitizer","volume":"12","author":"Yao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib64","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41422-024-00975-8","article-title":"Coding, or non-coding, that is the question","volume":"34","author":"Poliseno","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib65","article-title":"Non-coding RNAs in cancer therapy-induced cardiotoxicity: mechanisms, biomarkers, and treatments","volume":"9","author":"Sun","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.semcancer.2025.12.008_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41392-022-00975-3","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.semcancer.2025.12.008_bib67","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41576-024-00693-2","article-title":"Targeting and engineering long non-coding RNAs for cancer therapy","volume":"25","author":"Coan","year":"2024","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.semcancer.2025.12.008_bib68","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13578-022-00757-y","article-title":"Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology","volume":"12","author":"Nukala","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.semcancer.2025.12.008_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215723","article-title":"Cancer-related micropeptides encoded by ncRNAs: promising drug targets and prognostic biomarkers","volume":"547","author":"Setrerrahmane","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2025.12.008_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4161\/epi.26700","article-title":"Perspectives on the mechanism of transcriptional regulation by long non-coding RNAs","volume":"9","author":"Roberts","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/j.semcancer.2025.12.008_bib71","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fcell.2016.00128","article-title":"A lncRNA perspective into (Re)Building the heart","volume":"4","author":"Frank","year":"2016","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib72","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.vph.2018.01.003","article-title":"LncRNAs in vascular biology and disease","volume":"114","author":"Simion","year":"2019","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.semcancer.2025.12.008_bib73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vph.2018.03.003","article-title":"Long non-coding RNAs in vascular biology and disease","volume":"114","author":"Jae","year":"2019","journal-title":"Vasc. Pharm."},{"key":"10.1016\/j.semcancer.2025.12.008_bib74","doi-asserted-by":"crossref","DOI":"10.5935\/abc.20160005","article-title":"Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment","author":"Azevedo","year":"2016","journal-title":"Arq. Bras. Cardiol. 106 6269"},{"key":"10.1016\/j.semcancer.2025.12.008_bib75","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1161\/CIRCRESAHA.114.303265","article-title":"Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth","volume":"114","author":"Michalik","year":"2014","journal-title":"Circ. Res"},{"key":"10.1016\/j.semcancer.2025.12.008_bib76","doi-asserted-by":"crossref","unstructured":"Rahman and Mehnaz - 2024 - International Journal for Multidisciplinary Research (IJFMR).pdf.","DOI":"10.2139\/ssrn.5054029"},{"key":"10.1016\/j.semcancer.2025.12.008_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1372817","article-title":"Anticancer drugs and cardiotoxicity: the role of cardiomyocyte and non-cardiomyocyte cells","volume":"11","author":"Koukorava","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.semcancer.2025.12.008_bib78","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/iub.2210","article-title":"The role of lncRNA MALAT1 in cardiovascular disease","volume":"72","author":"Yan","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.semcancer.2025.12.008_bib79","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","article-title":"The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells","volume":"73","author":"Gutschner","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib80","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jcp.26759","article-title":"Functions and regulatory mechanisms of metastasis-associated lung adenocarcinoma transcript 1","volume":"234","author":"Lei","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib81","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.18632\/aging.103136","article-title":"Long-noncoding RNA MALAT1 sponges microRNA-92a-3p to inhibit doxorubicin-induced cardiac senescence by targeting ATG4a","volume":"12","author":"Xia","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.semcancer.2025.12.008_bib82","first-page":"1388","article-title":"lncRNA HOXB-AS3 protects doxorubicin-induced cardiotoxicity by targeting miRNA-875-3p","volume":"19","author":"Lu","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.semcancer.2025.12.008_bib83","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1038\/s41467-019-13259-2","article-title":"The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia","volume":"10","author":"Papaioannou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2025.12.008_bib84","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.omtn.2021.08.006","article-title":"Cardiomyocyte mitochondrial dynamic-related lncRNA 1 (CMDL-1) may serve as a potential therapeutic target in doxorubicin cardiotoxicity","volume":"25","author":"Aung","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.semcancer.2025.12.008_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153587","article-title":"The effects and mechanism of LncRNA NORAD on doxorubicin-induced cardiotoxicity","volume":"494","author":"Guan","year":"2023","journal-title":"Toxicology"},{"key":"10.1016\/j.semcancer.2025.12.008_bib86","first-page":"2695","article-title":"Long intergenic non\u2011coding RNA\u2011p21 mediates cardiac senescence via the Wnt\/beta\u2011catenin signaling pathway in doxorubicin-induced cardiotoxicity","volume":"17","author":"Xie","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.semcancer.2025.12.008_bib87","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s11658-022-00385-x","article-title":"lncRNA PVT1: a novel oncogene in multiple cancers","volume":"27","author":"Li","year":"2022","journal-title":"Cell Mol. Biol. Lett."},{"key":"10.1016\/j.semcancer.2025.12.008_bib88","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1667\/RADE-24-00089.1","article-title":"Long non-coding RNA PVT1 facilitates radiation-induced vascular endothelial cell injury through sponging microRNA-9-5p","volume":"202","author":"Wang","year":"2024","journal-title":"Radiat. Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib89","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ng.3673","article-title":"An inducible long noncoding RNA amplifies DNA damage signaling","volume":"48","author":"Schmitt","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2025.12.008_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061662","article-title":"Non-coding RNAs in cancer radiosensitivity: microRNAs and lncRNAs as regulators of radiation-induced signaling pathways","volume":"12","author":"Podralska","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.semcancer.2025.12.008_bib91","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ijbiomac.2021.03.075","article-title":"Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis-new insight and futuristic vision","volume":"180","author":"Huang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib92","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00018-023-04729-4","article-title":"Receptor tyrosine kinase inhibitors in cancer","volume":"80","author":"Ebrahimi","year":"2023","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.semcancer.2025.12.008_bib93","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-019-00614-3","article-title":"MEG3: an oncogenic long non-coding RNA in different cancers","volume":"25","author":"Al-Rugeebah","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109166","article-title":"LncRNA Meg3 knockdown reduces corneal neovascularization and VEGF-induced vascular endothelial angiogenesis via SDF-1\/CXCR4 and Smad2\/3 pathway","volume":"222","author":"Shen","year":"2022","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123742","article-title":"Long non-coding RNAs as mediators of tumor microenvironment and liver cancer cell communication","volume":"19","author":"Lin","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2025.12.008_bib96","first-page":"1367","article-title":"Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis","volume":"9","author":"Zhao","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib97","article-title":"Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway","volume":"39","author":"Zhang","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib98","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13287-018-0861-x","article-title":"Long noncoding RNA H19 upregulates vascular endothelial growth factor A to enhance mesenchymal stem cells survival and angiogenic capacity by inhibiting miR-199a-5p","volume":"9","author":"Hou","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.semcancer.2025.12.008_bib99","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-015-0426-x","article-title":"CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA","volume":"14","author":"Conigliaro","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2025.12.008_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188502","article-title":"Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer","volume":"1875","author":"Goyal","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.semcancer.2025.12.008_bib101","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.semcancer.2025.12.008_bib102","article-title":"siRNA-based knockdown of lncRNAs: a new modality to target tumor progression","volume":"266","author":"Khaleel","year":"2025","journal-title":"Pathol. Res Pr."},{"key":"10.1016\/j.semcancer.2025.12.008_bib103","series-title":"Mechanisms, and Applications (eds Yusuf Tutar & L\u00fctfi Tutar)","article-title":"Long non-coding RNAs - function","author":"Ghasemi","year":"2025"},{"key":"10.1016\/j.semcancer.2025.12.008_bib104","article-title":"Non-coding RNAs, cancer treatment and cardiotoxicity: a triad of new hope","volume":"36","author":"Mittal","year":"2023","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.semcancer.2025.12.008_bib105","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2025.12.008_bib106","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9085195","article-title":"Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics","volume":"2016","author":"Shi","year":"2016","journal-title":"Dis. Markers"},{"key":"10.1016\/j.semcancer.2025.12.008_bib107","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1602\/neurorx.1.2.182","article-title":"Biomarkers: potential uses and limitations","volume":"1","author":"Mayeux","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.semcancer.2025.12.008_bib108","article-title":"Plasma circulating lncRNAs: MALAT1 and NEAT1 as biomarkers of radiation-induced adverse effects in laryngeal cancer patients","volume":"15","author":"Mazurek","year":"2025","journal-title":"Diagn. (Basel)"},{"key":"10.1016\/j.semcancer.2025.12.008_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.613837","article-title":"Human induced pluripotent stem cells as a screening platform for drug-induced vascular toxicity","volume":"12","author":"Tu","year":"2021","journal-title":"Front Pharm."},{"key":"10.1016\/j.semcancer.2025.12.008_bib110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.stem.2020.02.011","article-title":"Multi-lineage human iPSC-derived platforms for disease modeling and drug discovery","volume":"26","author":"Sharma","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2025.12.008_bib111","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10238-024-01491-0","article-title":"lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer","volume":"24","author":"Bhat","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.semcancer.2025.12.008_bib112","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4939-3378-5_16","article-title":"Targeting long noncoding RNA with antisense oligonucleotide technology as cancer therapeutics","volume":"1402","author":"Zhou","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.semcancer.2025.12.008_bib113","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1261\/rna.25706","article-title":"Widespread siRNA \"off-target\" transcript silencing mediated by seed region sequence complementarity","volume":"12","author":"Jackson","year":"2006","journal-title":"RNA"},{"key":"10.1016\/j.semcancer.2025.12.008_bib114","doi-asserted-by":"crossref","first-page":"225","DOI":"10.20517\/jtgg.2024.12","article-title":"The potential therapeutic applications of long non-coding RNAs","volume":"8","author":"Tamblin-Hopper","year":"2024","journal-title":"J. Transl. Genet. Genom."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25001786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X25001786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:20:52Z","timestamp":1774005652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X25001786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":114,"alternative-id":["S1044579X25001786"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.12.008","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heartbreakers and healers: RNA rebels in cardio-oncology","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2025.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}